AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to ...
A recent study by researchers at Loma Linda University in California has found that including eggs in one’s diet can ...
The FDA has approved Auvelity for treating agitation in patients with dementia due to Alzheimer’s disease, Axsome ...
At WIRED Health, pioneering Alzheimer's researcher John Hardy outlined the stakes—and next steps—of where treatment is headed ...
The FDA approves Alzheimer agitation treatment Auvelity, the first non-antipsychotic option for dementia-related agitation in adults.
Researchers have identified a new potential weapon against Alzheimer’s: blocking a protein called PTP1B. In mice, this approach boosted memory and helped brain immune cells clear harmful plaque ...
The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness even without carrying the well-known mutations linked to it. In fact, ...
A long-awaited treatment seen as a significant step in the fight against Alzheimer’s disease has finally been approved in ...
As researchers investigate three distinct alzheimer’s patterns the potential is clear for more effective Alzheimer's ...
A proposed bipartisan bill could make it easier to detect Alzheimer’s earlier, by expanding access to testing often blocked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results